FDA
-
healthBlack Cohosh: Promising Menopause Relief or Risk?
Exploring the efficacy and safety of black cohosh for menopause symptoms amid rising popularity and regulatory concerns.
-
healthFDA Recalls Male Enhancement Chocolates Containing Hidden Drugs
Two chocolate products sold nationwide are recalled due to undisclosed pharmaceuticals that pose serious health risks.
-
healthAnother State Bans 'Gas Station Heroin' Amid National Crackdown
Tianeptine, dubbed 'gas station heroin,' faces new state bans as health officials warn of rising addiction and overdose risks.
-
healthFDA Endorses Human-Centric Drug Testing
The FDA advances new testing methods, moving beyond animal models to AI-driven and organ-on-chip technologies for faster, more accurate drug development.
-
health90,000 Bottles of Children's Ibuprofen Recalled Over Foreign Substance
Strides Pharma recalls 89,592 bottles of children's ibuprofen due to potential foreign contaminants.
-
healthFDA Links Raw Cheese to Outbreak; Maker Refuses Recall
FDA links raw cheddar cheese to E. coli outbreak; maker rejects findings and refuses voluntary recall.
-
healthFDA Cites Novo Nordisk for Failing to Report Patient Deaths Linked to GLP-1 Drugs
The FDA issued a warning letter accusing Novo Nordisk of systemic failures in reporting serious side effects-including deaths-of patients using Ozempic and Wegovy.
-
healthStanford’s James Zou on AI as Co-Scientist in Medicine
Stanford biomedical AI expert James Zou discusses autonomous AI agents, clinical trial inclusivity, FDA-cleared algorithms, real-world data challenges, and wearable-driven disease prediction.